We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+2.03%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$23.2B
AUM Growth
+$4.57B
Cap. Flow
+$4.34B
Cap. Flow %
18.68%
Top 10 Hldgs %
24.47%
Holding
3,215
New
812
Increased
777
Reduced
812
Closed
734

Top Buys

Rank Stock Value
1
FRC
First Republic Bank
FRC
+$286M
2
CI icon
Cigna
CI
+$183M
3
HON icon
Honeywell
HON
+$156M
4
COP icon
ConocoPhillips
COP
+$150M
5
ABT icon
Abbott
ABT
+$120M

Sector Composition

Rank Sector Weight
1 Technology 13.38%
2 Consumer Discretionary 11.26%
3 Healthcare 10.95%
4 Financials 10.85%
5 Industrials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLV icon
1701
iShares Silver Trust
SLV
$28.6B
$340K ﹤0.01%
15,379
-14,270
-48% -$296K
TCFC
1702
DELISTED
The Community Financial Corporation Common Stock
TCFC
$339K ﹤0.01%
10,229
+4,385
+75% +$169K
CCS icon
1703
Century Communities
CCS
$1.95B
$339K ﹤0.01%
+5,301
New +$316K
LKFN icon
1704
Lakeland Financial Corp
LKFN
$1.56B
$338K ﹤0.01%
5,400
-42,044
-89% -$2.93M
MSA icon
1705
Mine Safety
MSA
$6.73B
$338K ﹤0.01%
+2,533
New +$341K
ALNT icon
1706
Allient
ALNT
$1.47B
$337K ﹤0.01%
+8,728
New +$346K
FENC icon
1707
Fennec Pharmaceuticals
FENC
$344M
$334K ﹤0.01%
40,195
+22,923
+133% +$213K
TARO
1708
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$333K ﹤0.01%
+13,694
New +$399K
SRI icon
1709
Stoneridge
SRI
$200M
$333K ﹤0.01%
+17,808
New +$382K
LCTX icon
1710
Lineage Cell Therapeutics
LCTX
$277M
$333K ﹤0.01%
221,946
+84,378
+61% +$118K
DLX icon
1711
Deluxe
DLX
$1.19B
$333K ﹤0.01%
+20,792
New +$379K
FIP icon
1712
FTAI Infrastructure
FIP
$473M
$332K ﹤0.01%
+110,659
New +$337K
CVCO icon
1713
Cavco Industries
CVCO
$4.33B
$331K ﹤0.01%
1,043
-14,552
-93% -$4.03M
CCEP icon
1714
Coca-Cola Europacific Partners
CCEP
$49.3B
$331K ﹤0.01%
+5,587
New +$312K
EVBN
1715
DELISTED
Evans Bancorp Inc
EVBN
$328K ﹤0.01%
9,771
+3,388
+53% +$128K
XSD icon
1716
State Street SPDR S&P Semiconductor ETF
XSD
$2.69B
$327K ﹤0.01%
1,567
MNSB icon
1717
MainStreet Bancshares
MNSB
$163M
$327K ﹤0.01%
13,916
+5,981
+75% +$164K
LCNB icon
1718
LCNB Corp
LCNB
$286M
$326K ﹤0.01%
19,953
+8,929
+81% +$159K
OXM icon
1719
Oxford Industries
OXM
$571M
$326K ﹤0.01%
3,086
-6,015
-66% -$672K
IVE icon
1720
iShares S&P 500 Value ETF
IVE
$49.1B
$326K ﹤0.01%
2,146
-4,631
-68% -$700K
CHCT
1721
Community Healthcare Trust
CHCT
$530M
$326K ﹤0.01%
+8,898
New +$347K
OBE
1722
Obsidian Energy
OBE
$678M
$325K ﹤0.01%
50,734
-7,902
-13% -$51.4K
INO icon
1723
Inovio Pharmaceuticals
INO
$54M
$323K ﹤0.01%
+32,856
New +$560K
AESI icon
1724
Atlas Energy Solutions
AESI
$1.29B
$323K ﹤0.01%
+18,966
New +$311K
EEMV icon
1725
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.45B
$322K ﹤0.01%
5,905
-7,953
-57% -$431K

Similar funds

Qube Research & Technologies (QRT)'s Q1 2023 Portfolio in Review

As of Q1 2023, Qube Research & Technologies (QRT) held 3,215 positions worth $23.2B, up 24% from $18.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Qube Research & Technologies (QRT) deployed $4.34B of net new capital in Q1 2023, opening 812 new positions and adding to 777 existing holdings. Its largest new stake was First Republic Bank: 2,786,874 shares worth $39M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $180M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q1 2023 buy was First Republic Bank: 2,786,874 shares worth $39M.
  • Qube Research & Technologies (QRT) added most to Cigna in Q1 2023, an estimated $183M increase.
  • Qube Research & Technologies (QRT)'s biggest Q1 2023 reduction was Apple, cutting an estimated $180M.
  • Qube Research & Technologies (QRT) fully exited Vertex Pharmaceuticals in Q1 2023, selling an estimated $123M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 24% of its $23.2B portfolio in Q1 2023.
  • Qube Research & Technologies (QRT) opened 812 new positions and closed 734 in Q1 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 24% quarter-over-quarter to $23.2B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2023, filed 15 May 2023.